Pierre Dillard

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Top Venues

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Dillard, Nicholas Paul Casey, Sylvie Pollmann, Patrik Vernhoff, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors. Oncoimmunology 10 (1) (2021)
Hakan Köksal, Pierre Dillard, Sarah E Josefsson, Solrun Melkorka Maggadottir, Sylvie Pollmann, Anne Fåne, Yngvild Nuvin Blaker, Klaus Beiske, Kanutte Huse, Arne Kolstad, Harald Holte, Gunnar Kvalheim, Erlend B Smeland, June Helen Myklebust, Else Marit Inderberg, Sébastien Wälchli
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood advances 3 (8) (2020)
Nadia Mensali, Amalie C Grenov, Niladri Bhusan Pati, Pierre Dillard, Marit Renée Myhre, Gustav Gaudernack, Gunnar Kvalheim, Else Marit Inderberg, Oddmund Bakke, Sébastien Wälchli
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity. Oncoimmunology 8 (3) (2019)
Nadia Mensali, Marit Renée Myhre, Pierre Dillard, Sylvie Pollmann, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy. Cancer immunology, immunotherapy : CII 68 (8) (2019)